Quan Li-Quan

No. 136, Jingzhou Street
Xiangyang, 441021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.

Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.

Journal: Communications medicine

Published: September 18, 2025

Hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumors.

Hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumors.

Journal: Research and practice in thrombosis and haemostasis

Published: June 30, 2025

Three dyes for use in tissue marking inks for biopsies and other small specimens.

Three dyes for use in tissue marking inks for biopsies and other small specimens.

Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission

Published: June 05, 2024

Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer.

Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer.

Journal: Journal of cancer research and clinical oncology

Published: May 05, 2024

Patient-Controlled Subcutaneous Analgesia with Hydromorphone versus Oral Oxycontin for Opioid Titration of Cancer Pain: A Prospective Multicenter Randomized Trial.

Patient-Controlled Subcutaneous Analgesia with Hydromorphone versus Oral Oxycontin for Opioid Titration of Cancer Pain: A Prospective Multicenter Randomized Trial.

Journal: Journal of pain research

Published: December 11, 2023

MNK/eIF4E inhibition overcomes anlotinib resistance in non-small cell lung cancer.

MNK/eIF4E inhibition overcomes anlotinib resistance in non-small cell lung cancer.

Journal: Fundamental & clinical pharmacology

Published: April 21, 2022

Clinical Characteristics and Prognosis of Cervical Cancer Patients with Human Immunodeficiency Virus Infection: A Retrospective Study.

Clinical Characteristics and Prognosis of Cervical Cancer Patients with Human Immunodeficiency Virus Infection: A Retrospective Study.

Journal: Gynecologic and obstetric investigation

Published: January 09, 2022

Farrerol exhibits inhibitory effects on lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway.

Farrerol exhibits inhibitory effects on lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway.

Journal: Journal of biochemical and molecular toxicology

Published: September 22, 2021

Cobimetinib Sensitizes Cervical Cancer to Paclitaxel via Suppressing Paclitaxel-Induced ERK Activation.

Cobimetinib Sensitizes Cervical Cancer to Paclitaxel via Suppressing Paclitaxel-Induced ERK Activation.

Journal: Pharmacology

Published: September 01, 2021

Abemaciclib sensitizes HPV-negative cervical cancer to chemotherapy via specifically suppressing CDK4/6-Rb-E2F and mTOR pathways.

Abemaciclib sensitizes HPV-negative cervical cancer to chemotherapy via specifically suppressing CDK4/6-Rb-E2F and mTOR pathways.

Journal: Fundamental & clinical pharmacology

Published: July 29, 2019

The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells.

The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells.

Journal: Gene

Published: April 17, 2018

[Retracted] MicroRNA‑212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3.

[Retracted] MicroRNA‑212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3.

Journal: Molecular medicine reports

Published: April 13, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026